Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic.
about
Future therapies for food allergiesT Cell Epitope Peptide Therapy for Allergic DiseasesImmunoregulatory T cell epitope peptides: the new frontier in allergy therapyPathogenic CD4+ T cells in patients with asthma.Food allergy diagnosis and therapy: where are we now?Elevated antigen-driven IL-9 responses are prominent in peanut allergic humansInduction of allergic responses to peanut allergen in sheep.MHC class II expression in human basophils: induction and lack of functional significanceHeterogeneous responses and cross reactivity between the major peanut allergens Ara h 1, 2,3 and 6 in a mouse model for peanut allergyJug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy.Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickensWhat's new in the diagnosis and management of food allergy in children?A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeuticImproving the safety of oral immunotherapy for food allergy.Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.Vaccines and immunomodulatory therapies for food allergy.Therapeutics in food allergy: the current state of the art.Peptide immunotherapy for childhood allergy - addressing translational challenges.Characterization of CD4+ T cell subsets in allergy.Current and emerging immunotherapeutic approaches to treat and prevent peanut allergy.Food allergy: management, diagnosis and treatment strategies.Developing therapies for peanut allergy.Immunomodulating peptides for food allergy prevention and treatment.T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy.Immunotherapy of Food Allergy: a Comprehensive Review.Unique and cross-reactive T cell epitope peptides of the major Bahia grass pollen allergen, Pas n 1.The current state of food allergy therapeutics.In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children.Extended boiling of peanut progressively reduces IgE allergenicity while retaining T cell reactivity.An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy.Heterogeneity of Ara h Component-Specific CD4 T Cell Responses in Peanut-Allergic Subjects.
P2860
Q24630319-6ACB4896-C931-49B8-B756-3257576E5DB1Q26771989-13638258-F9BF-41ED-843A-EE565CA03925Q26822702-1F57320C-AC24-46B1-BB82-6AE4ED6C0069Q30252507-E908C2A5-7E91-44E1-BC80-B5B7A89C734BQ34000536-B1063CFB-0B86-4276-B65C-A7C50F0405ADQ34446837-E0928E58-636E-4ED8-B86A-3B03CF0505D8Q34531827-F1635CEB-0AEA-4A56-B7EE-57BA847366D7Q35069773-9275AD49-6200-4E0A-B776-869D6673AB3DQ35206546-CB0D479C-7A3A-4CAF-B5CD-20506E3111E6Q36055311-3FF44A37-E8D6-45AD-9120-7C87164245B3Q36353886-70115A1A-24FF-43AF-B006-04DEF519945DQ36813250-F61AFEE2-A152-4523-A616-633A137EF911Q36874668-F88E3CF0-0A15-4A41-98F7-56E771A7E4F4Q37005082-92C368C7-6280-4193-8DAD-B1F25403231CQ37106401-37D8646E-CDBA-4DF6-9B7C-E0F79AD8A4DDQ37744450-F32B1511-62A0-4341-BAA8-E92F2E9E266CQ37957033-8DB2685E-A5CF-4BB3-A1D7-BD2B70611E64Q37958752-DFFF1627-0D31-40D6-9254-12C5F489656FQ37992746-768B460B-EA05-4599-A1AB-C39E468711F4Q38034308-8C4B1296-7296-4A01-85CD-4F9E39E53D8CQ38068470-12E8702F-73CA-487F-87B3-91C70FEE930DQ38119552-BFA68F11-2D59-4852-9810-71F38AFCCAE8Q38296706-DF04ECC2-925E-4208-A9B8-871E7C57C476Q39094939-0079F588-0C12-46A3-95F4-A494D2CDC60BQ46198561-5516F327-5530-4F66-9A0D-E0747148BD41Q46222311-236BC1A1-3DDD-4349-AD43-11A3D6605CC4Q46640921-1E9C8591-7FC7-4F28-96BD-5557A60E53FAQ47897158-790884B7-6FB8-4C64-88A0-9AABB6D2B315Q51282104-34320F63-B60D-4028-A229-16DAA71F30DDQ52820148-1283FC7A-94EA-4127-A2BF-909CC20F50D5Q52837476-B6B5CA3E-EC3E-420A-AF96-E1776A24945AQ53089331-1D84A86F-612D-4C89-AA9D-3A46D6706960Q55516309-0D8F3099-F82B-40A9-92B7-BDA8F3F34C30
P2860
Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Ara h 2 peptides containing do ...... a peanut allergy therapeutic.
@en
Ara h 2 peptides containing do ...... a peanut allergy therapeutic.
@nl
type
label
Ara h 2 peptides containing do ...... a peanut allergy therapeutic.
@en
Ara h 2 peptides containing do ...... a peanut allergy therapeutic.
@nl
prefLabel
Ara h 2 peptides containing do ...... a peanut allergy therapeutic.
@en
Ara h 2 peptides containing do ...... a peanut allergy therapeutic.
@nl
P2093
P1476
Ara h 2 peptides containing do ...... a peanut allergy therapeutic.
@en
P2093
April Dacumos-Hill
Astrid L Voskamp
Jennifer M Rolland
Karen Symons
Sara R Prickett
P304
608-15.e1-5
P356
10.1016/J.JACI.2010.09.027
P407
P577
2010-11-18T00:00:00Z